# US 2012/0252860 A1 · Novel N, N'-Hydrazino-bis-isatin Derivatives with Selective Activity Against Multidrug-Resistant Cancer Cells

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0252860 A1
- Document ID: US20120252860A1
- Status: Published application
- Kind: A1
- Application number: 13/423,040
- Filed: 2012-03-16
- Published: 2012-10-04
- Earliest claimed: 2011-03-31
- Assignees: King Saud University
- Inventors: Tarek Aboul-Fadl Mohamed Hassan; Adnan Ahmed Kadi; Hatem Abdel-Khader Abdel-Aziz
- Web page: https://patentgrep.com/patent/US20120252860A1

## CPC

- C07D 209/40: Nitrogen atoms, not forming part of a nitro radical, e.g. isatin semicarbazone
- A61P 35/00: Antineoplastic agents
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The invention is directed to a compound of Formula (I), wherein R is selected from the group consisting of hydrogen atom and unsubstituted or substituted phenyl group; R1 is selected from the group consisting of hydrogen atom and unsubstituted or substituted phenyl group; X is selected from the group consisting of hydrogen atom or halogen atom; and Y is selected from the group consisting of hydrogen atom, halogen atom, C1-C4 alkyl group, nitro group, and —OCF3 group, as well as for its use in therapy, preferably for the treatment of cancer, and to a related pharmaceutical composition, the use of the compound for the manufacture of a medicament for the respective medical indication, and a method of synthesis of the compounds of the invention.

## Claims

### Claim 1

A compound of Formula (I)
wherein
R is selected from the group consisting of hydrogen atom and unsubstituted or substituted phenyl group;
R1 is selected from the group consisting of hydrogen atom and unsubstituted or substituted phenyl group;
X is selected from the group consisting of hydrogen atom or halogen atom; and
Y is selected from the group consisting of hydrogen atom, halogen atom, C1-C4 alkyl group, nitro group, and —OCF3 group,
wherein the compounds in which R, R1, X and Y are hydrogen atoms and in which R and R1 are hydrogen atoms and X and Y are bromine atoms are excluded.

### Claim 2 (depends on 1)

The compound according to claim 1, wherein R is selected from the group consisting of hydrogen atom and unsubstituted phenyl group.

### Claim 3 (depends on 1)

The compound according to claim 1, wherein R1 is selected from the group consisting of hydrogen atom and unsubstituted phenyl group.

### Claim 4 (depends on 1)

The compound according to any of claim 1, wherein X is selected from the group consisting of hydrogen atom and fluorine atom.

### Claim 5 (depends on 1)

The compound according to claim 1, wherein Y is selected from the group consisting of hydrogen atom, fluorine atom, chlorine atom, bromine atom, methyl group, nitro group and —OCF3 group.

### Claim 6

The compound of Formula (I)
wherein
R is selected from the group consisting of hydrogen atom and unsubstituted or substituted phenyl group;
R1 is selected from the group consisting of hydrogen atom and unsubstituted or substituted phenyl group;
X is selected from the group consisting of hydrogen atom or halogen atom; and
Y is selected from the group consisting of hydrogen atom, halogen atom, C1-C4 alkyl group, nitro group, and —OCF3 group for use in therapy.

### Claim 7 (depends on 6)

The compound according to claim 6 for the treatment of cancer.

### Claim 8 (depends on 7)

The compound according to claim 7 for the treatment of multidrug resistant cancer.

### Claim 9 (depends on 6)

A pharmaceutical composition comprising a compound according to claim 6 together with at least one pharmaceutically acceptable excipient.

### Claim 10

A use of a compound of Formula (I)
wherein
R is selected from the group consisting of hydrogen atom and unsubstituted or substituted phenyl group;
R1 is selected from the group consisting of hydrogen atom and unsubstituted or substituted phenyl group;
X is selected from the group consisting of hydrogen atom or halogen atom; and
Y is selected from the group consisting of hydrogen atom, halogen atom, C1-C4 alkyl group, nitro group, and —OCF3 group for the manufacture of a medicament for the treatment of cancer.

### Claim 11 (depends on 10)

The use according to claim 10 for the manufacture of a medicament of multidrug resistant cancer.

### Claim at position 12

12-14. (canceled)
